HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer

BACKGROUND: Tamoxifen resistance remains a significant clinical challenge for the therapy of ER-positive breast cancer. It has been reported that the upregulation of transcription factor SOX9 in ER(+) recurrent cancer is sufficient for tamoxifen resistance. However, the mechanisms underlying the reg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Xue, Yue, Lian, Wenwen, Zhi, Jiaqi, Yang, Wenjuan, Li, Qianjin, Guo, Xingyi, Gao, Jiahao, Qu, Hao, Lin, Weiqiang, Li, Zhongqi, Lai, Lihua, Wang, Qingqing
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964674/
https://ncbi.nlm.nih.gov/pubmed/31690832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0625-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados